Search research publications and outputs

  1. 2016
  2. Cancer Drugs Fund requires further reform: Reliance on “real world” observational data undermines evidence base for clinical practice

    Grieve, R., Abrams, K., Claxton, K. P., Goldacre, B., James, N., Nicholl, J., Parmar, M., Parker, C., Sekhon, J. S., Smeeth, L., Spiegelhalter, D. & Sculpher, M. J., 27 Sep 2016

    Article in British medical journal

  3. Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal

    Morton, A., Adler, A. I., Bell, D., Briggs, A., Brouwer, W., Claxton, K., Craig, N., Fischer, A., McGregor, P. & van Baal, P., Aug 2016

    Article in Health Economics

  4. International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value Framework

    Malone, D. C., Berg, N. S., Claxton, K., Garrison, L. P., IJzerman, M., Marsh, K., Neumann, P. J., Sculpher, M., Towse, A., Uyl-de Groot, C. & Weinstein, M. C., 13 Jun 2016

    Article in Journal of Clinical Oncology